Vision-based Ultrasonic Robot Autonomous Scanning Research
Launched by RONGQIN ZHENG · Sep 1, 2021
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Vision-based Ultrasonic Robot Autonomous Scanning Research" is studying a new robot called MGIR3-US, which is designed to perform ultrasound examinations remotely. The goal of the study is to see how well this robot works and if it can be used safely for patients needing ultrasound tests.
To participate in this trial, patients must be between the ages of 18 and 65 and agree to use the MGIR3 robot for their ultrasound exam. However, people who have injuries at the area being examined, are pregnant, or feel scared about using the robot will not be able to join the study. If you decide to participate, you can expect to have your ultrasound done with the help of this advanced robot, which aims to make the process easier and more efficient. It's important to know that this trial is currently not yet recruiting participants, so there will be more information available in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who agree using MGIR3 to do ultrasonic examinations
- • age from 18 to 65
- Exclusion Criteria:
- • Patients who has trauma on the inspection site or on the body surface
- • Pregnant patients.
- • Patients who are afraid of MGIR3-US
About Rongqin Zheng
Rongqin Zheng is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, Zheng oversees the design, implementation, and management of clinical trials that adhere to the highest ethical and regulatory standards. Leveraging a collaborative network of healthcare professionals and researchers, Zheng aims to facilitate the development of novel treatments while ensuring participant safety and data integrity. Through rigorous scientific inquiry and a patient-centered approach, Zheng is poised to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Jie Ren, doctor
Principal Investigator
the third affiated hosptial of Sun Yat-sun University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials